One challenge in cancer research is how to translate the findings obtained with cell culture in vitro to the complex behaviors of human cancers in vivo. We previously identified a hypoxia gene signature in cultured cells to allow us infer the level of hypoxia pathway activities in many human cancers to identify patients with strong hypoxia response. By relating in vitro cell culture models to their in vivo cancer counterparts via the common language of """"""""gene signature"""""""", we found we can recognize the molecular programs in human cancers reflecting defined perturbations in culture to explore their prognostic significance and phenotypic characteristics. Tumor microenvironments play critical roles in determining tumor behaviors and treatment responses and are featured by hypoxia and lactic acidosis. Although lactic acidosis is reported to be associated with tumor aggression and poor clinical outcomes, we know little about how cells respond to lactic acidosis, their prognostic significance in human cancers and best ways to identify tumors with this feature. In this proposal, we will use global gene expression in cell culture and human cancers to understand the role lactic acidosis in human cancers. We will first determine the transcriptional responses to lactic acidosis in various cultured cells to define """"""""gene signatures"""""""" reflecting lactic acidosis. The possibility of abolishing this response by inhibiting Acid-Sensing Ion Channel (ASICs) or hypoxia-inducible factor (HIF) proteins will be tested. Secondly, the gene expression pattern associated with high lactate levels in tumors will be determined based on gene expression analysis of human cancers with measured lactate levels. The lactic acidosis gene signatures, obtained either in cell culture or tumors, will be used as molecular gauges to determine the level of lactic acidosis response in tumors based on gene expression. The prognostic significances of these gene signatures will be further tested in many other gene expression studies and the composition of molecular pathways lactic acidosis tumors will also be identified with advanced bioinformatics. To allow us to identify lactic acidosis cancers with high clinical risks, we will select molecular markers based on our gene expression studies. The spatial distribution of marker expression in tumor tissues will be compared to hypoxia markers (CA9) and measured tumor physiology parameters. Their prognostic values of these candidate markers will be further determined on multiple cancer tissue microarrays.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA125618-03
Application #
7623175
Study Section
Tumor Progression and Metastasis Study Section (TPM)
Program Officer
Thurin, Magdalena
Project Start
2007-07-02
Project End
2012-04-30
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
3
Fiscal Year
2009
Total Cost
$266,760
Indirect Cost
Name
Duke University
Department
Genetics
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Lin, Chao-Chieh; Kitagawa, Mayumi; Tang, Xiaohu et al. (2018) CoA synthase regulates mitotic fidelity via CBP-mediated acetylation. Nat Commun 9:1039
Chen, Po-Han; Chi, Jen-Tsan; Boyce, Michael (2018) Functional crosstalk among oxidative stress and O-GlcNAc signaling pathways. Glycobiology 28:556-564
Allott, E H; Macias, E; Sanders, S et al. (2017) Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model. Prostate Cancer Prostatic Dis 20:165-171
Alfaqih, Mahmoud A; Nelson, Erik R; Liu, Wen et al. (2017) CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer. Cancer Res 77:1662-1673
Chen, Po-Han; Smith, Timothy J; Wu, Jianli et al. (2017) Glycosylation of KEAP1 links nutrient sensing to redox stress signaling. EMBO J 36:2233-2250
Tang, X; Ding, C-K; Wu, J et al. (2017) Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling. Oncogene 36:4235-4242
Scott-Emuakpor, Jem; Allot, Emma; Johnson, Stacy A et al. (2017) Angiotensin receptor signaling and prostate tumor growth in mice. J Exp Ther Oncol 11:107-115
Padró, Mercè; Louie, Raymond J; Lananna, Brian V et al. (2017) Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells. BMC Cancer 17:203
Tang, Xiaohu; Wu, Jianli; Ding, Chien-Kuang et al. (2016) Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas. Cancer Res 76:1892-903
Syu, Jhih-Pu; Chi, Jen-Tsan; Kung, Hsiu-Ni (2016) Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia. Oncotarget 7:14659-72

Showing the most recent 10 out of 48 publications